EUVIMEDEUVIMED entdecken
Editorial

Broader Options for Experimental Clinical Research in Melanoma — Time for Adaptive Platform Trials?

Thomas A Trikalinos

NEJM Evidence · 2024

DOI: 10.1056/evide2400284 ↗

Kurz gefasst

Editorial in der Zeitschrift NEJM Evidence, 2024. Verfasst von Thomas A Trikalinos. Beteiligte Einrichtung: Departments of Health Services, Policy, and Practice and Biostatistics, Brown University School of Public Health, Providence, RI. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHumansClinical Trials as TopicSkin NeoplasmsBiomedical ResearchAdaptive Clinical Trials as Topic

Autor:innen und Institutionen

  • Departments of Health Services, Policy, and Practice and Biostatistics, Brown University School of Public Health, Providence, RI.

Zitieren

APA

Trikalinos, T. A. (2024). Broader Options for Experimental Clinical Research in Melanoma — Time for Adaptive Platform Trials?. NEJM Evidence. https://doi.org/10.1056/evide2400284

Vancouver

Trikalinos TA. Broader Options for Experimental Clinical Research in Melanoma — Time for Adaptive Platform Trials?. NEJM Evidence. 2024. doi:10.1056/evide2400284

BibTeX
@article{Trikalinos2024,
  author = {Trikalinos, Thomas A},
  title = {Broader Options for Experimental Clinical Research in Melanoma — Time for Adaptive Platform Trials?},
  journal = {NEJM Evidence},
  year = {2024},
  doi = {10.1056/evide2400284}
}
Kostenlos starten →